Single-Dose Fluconazole for Vulvovaginal Candidiasis
- 1 February 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 107 (2, Part 1) , 310-313
Abstract
OBJECTIVE: To estimate the effect of a single oral 150-mg dose of fluconazole on the prothrombin time of women on long-term warfarin therapy. METHODS: Women on warfarin therapy for 6 months or more with no change in dose within 4 weeks of the study, and a prothrombin time (PT) with an International Normalized Ratio (INR) between 2 and 3 were invited to participate. Two consecutive baseline PTs were obtained (days –1 and 0), and women were given 150 mg of fluconazole. Prothrombin times were measured on days 2, 5, and 8 of the study. The change in PT was calculated from the difference between the baseline PT on day 0 and the PT during the study period. To detect a 10% difference in a PT (approximately 2.1 seconds) of a patient with an INR of 2.0, at P < .05 and a power of 90%, 5 subjects are required. RESULTS: Six women participated. The mean (± standard deviation) PT for day 0 was 27.7 ± 4.1 seconds or INR 2.6 ± 0.4. The PT increased 11% at day 2, 34% at day 5, and 2% at day 8; these differences were not statistically significant. However, one half of the women had either a clinically relevant increase of the INR greater than 4, or bleeding that required their dosage of warfarin to be decreased. CONCLUSION: A single 150-mg oral dose of fluconazole may increase the PT to a clinically relevant level in a woman on chronic warfarin therapy. Clinicians should monitor the PT carefully after a single dose of fluconazole. LEVEL OF EVIDENCE: II-2Keywords
This publication has 14 references indexed in Scilit:
- KIIV, AN IN VIVO PARAMETER FOR PREDICTING THE MAGNITUDE OF A DRUG INTERACTION ARISING FROM COMPETITIVE ENZYME INHIBITIONDrug Metabolism and Disposition, 2003
- Spinal epidural haematoma as a result of warfarin/fluconazole drug interactionEuropean Journal of Emergency Medicine, 2002
- Oral versus intra‐vaginal imidazole and triazole anti‐fungal agents for the treatment of uncomplicated vulvovaginal candidiasis (thrush): a systematic reviewBJOG: An International Journal of Obstetrics & Gynaecology, 2002
- Vaginal colonization by Candida in asymptomatic women with and without a history of recurrent vulvovaginal candidiasisObstetrics & Gynecology, 2000
- Vulvovaginal candidiasis: Epidemiologic, diagnostic, and therapeutic considerationsAmerican Journal of Obstetrics and Gynecology, 1998
- Fluconazole—Warfarin InteractionAnnals of Pharmacotherapy, 1994
- Case Report: Potentiation of Warfarin by FluconazoleThe American Journal of the Medical Sciences, 1993
- Clinical Pharmacokinetics of FluconazoleClinical Pharmacokinetics, 1993
- Possible Potentiation of Warfarin by FluconazoleDICP, 1990
- Fluconazole in the treatment of candidal prosthetic valve endocarditis.BMJ, 1988